🔗 Share this article

The Nobel Prize in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the immune system attacks dangerous infections while protecting the healthy tissues.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The research identified specialized "sentinels" within the defense system that eliminate malfunctioning immune cells capable of harming the body.

The findings are now enabling innovative treatments for immune disorders and cancer.

These winners will share a monetary award valued at 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from severe autoimmune diseases," commented the chair of the award panel.

This team's studies explain a core question: How does the defense system defend us from countless invaders while keeping our healthy cells intact?

The immune system employs immune cells that search for indicators of disease, even pathogens and germs it has never encountered.

Such defenders employ sensors—called receptors—that are produced randomly in countless combinations.

This gives the defense network the ability to fight a broad range of invaders, but the randomness of the process inevitably produces white blood cells that can attack the body.

Protectors of the Body

Scientists earlier knew that some of these harmful white blood cells were eliminated in the thymus—the site where immune cells mature.

The latest award recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the body to neutralize any defenders that attack the body's own tissues.

It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "The discoveries have established a new field of research and spurred the development of new treatments, for example for cancer and autoimmune diseases."

In malignancies, regulatory T-cells block the body from attacking the tumor, so research are focused on lowering their numbers.

For autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar method could also be useful in minimizing the risks of organ transplant rejection.

Pioneering Studies

Prof Sakaguchi, of Osaka University, performed tests on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from other animals could prevent the illness—implying there was a system for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the identification of a genetic factor vital for the way regulatory T-cells operate.

"The groundbreaking work has revealed how the immune system is kept in check by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," commented a leading physiology expert.

"This research is a striking illustration of how fundamental biological research can have broad consequences for human health."